Clinical Study

AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients

Figure 3

Progression-free survival of patients with low or high AGR2 tumor expression is determined using Kaplan-Meier curves. (a) Determination of PFS with respect to AGR2 mRNA levels. There were 4 censored observations in survival curve for low AGR2 mRNA expression and 2 censored observations in survival curve for high AGR2 mRNA level. (b) Determination of PFS with respect to AGR2 IHC staining. There were no censored observations in survival curve for low AGR2 IHC level and 6 censored observations in survival curve for high AGR2 IHC level. Hazard ratio (HR) with 95% CI as well as value calculated using log-rank test is provided for both curves.
761537.fig.003a
(a)
761537.fig.003b
(b)